Morgan Stanley (NYSE:MS) analyst Nigel Dally maintained a Buy rating on Metlife (NYSE:MET) on Thursday, setting a price target of $70, which is approximately 15.15% above the present share price of $60.79.
Dally expects Metlife to post earnings per share (EPS) of $0.00 for the second quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Strong Buy rating of shares in Metlife, with an average price target of $60.88.
The analysts price targets range from a high of $69 to a low of $52.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $19.42 billion and a net profit of $0. The company's market cap is $53.76 billion.
According to TipRanks.com, Morgan Stanley analyst Nigel Dally is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 18.3% and a 63.41% success rate.
Headquartered in New York, MetLife, Inc. is among the largest global providers of insurance and financial services to individual and institutional customers. It offers life insurance, annuities, employee benefits and asset management services. The company operates through the following segments: U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings.